What is the relevance of FoxP3 in the tumor microenvironment and cancer outcomes?
Authors:
- 25 March 2024
- journal article
- research article
- Published by Taylor & Francis in Expert Review of Clinical Immunology
- Vol. 20 (8) , 803-809
Abstract
1. The tumor microenvironment (TME) is comprised of different types of cellular and non-cellular components. These components include immune cells, stromal cells, adipocytes, surrounding blood vess...Keywords
This publication has 64 references indexed in Scilit:
- TCR-induced FOXP3 expression by CD8+ T cells impairs their anti-tumor activityCancer Letters, 2022
- Helios is a marker, not a driver, of human Treg stabilityEuropean Journal of Immunology, 2021
- FoxP3+ T regulatory cells in cancer: Prognostic biomarkers and therapeutic targetsCancer Letters, 2020
- Helios+ and Helios− Treg subpopulations are phenotypically and functionally distinct and express dissimilar TCR repertoiresEuropean Journal of Immunology, 2019
- The expression of FOXP3 and its role in human cancersBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2019
- Higher densities of Foxp3+ regulatory T cells are associated with better prognosis in triple-negative breast cancerBreast Cancer Research and Treatment, 2017
- Increased proportion of FoxP3+ regulatory T cells in tumor infiltrating lymphocytes is associated with tumor recurrence and reduced survival in patients with glioblastomaCancer Immunology, Immunotherapy, 2015
- High frequency of tumor‐infiltrating FOXP3+ regulatory T cells predicts improved survival in mismatch repair‐proficient colorectal cancer patientsInternational Journal of Cancer, 2010
- Up-regulation of Foxp3 inhibits cell proliferation, migration and invasion in epithelial ovarian cancerCancer Letters, 2010
- Prognostic significance of tumor-infiltrating T-lymphocytes in primary and metastatic lesions of advanced stage ovarian cancerCancer Immunology, Immunotherapy, 2008